Founders

Proteocyte acknowledges the contributions of its founding members.

Proteocyte was founded upon building on the extensive pre-cancer research by Professors Ranju Ralhan, PhD and Michael Siu, PhD, York University and further developed clinically by Dr. Paul Walfish and Dr. Kenneth Pritzker, University of Toronto. The purpose was to provide healthcare professionals with timely, objective and quantifiable biomarker information about pre-cancer and cancers to help manage patients thereby significantly improving patient outcomes.

Dr. Paul Walfish

Dr. Paul Walfish

Ranju Ralhan

Ranju Ralhan

Michael Siu

Michael Siu

Dr. Ken Pritzker

Dr. Ken Pritzker

Sign up, read up, stay informed!

Join our mailing list to stay up-to-date with the latest news and activities from Proteocyte.

Thank you for subscribing to our newsletter!